CIK 0001585608 · Non-accelerated filer<br>Smaller reporting company
Jaguar Health, Inc.
Sign in to watch- Ticker
- JAGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 415-371-8300
- Business address
- 200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
- Former names
- Jaguar Animal Health, Inc.
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- DEF 14A Proxy Proxy Statement
- DEFA14A Proxy Proxy Materials
- S-3 Offering Registration Statement
- 8-K Event Executive or director change
- PRE 14A Proxy Proxy Statement (Preliminary)
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-K Report Annual Report
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- NT 10-K Other NT 10-K
- 8-K Event Executive or director change
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
Page 41 of 56 · 1,115 filings